4SCAR‐GD2‐modified T‐cell therapy in neuroblastoma with MYCN amplification: A case report with over 4‐year follow‐up data

• Hlavní autoři: Xiao Xu (Autor), Wen Zhao (Autor), Zhixia Yue (Autor), Maoquan Qin (Autor), Mei Jin (Autor), Lung‐Ji Chang (Autor), Xiaoli Ma (Autor)
• Médium: Kniha
• Vydáno: Wiley, 2020-03-01T00:00:00Z.
• Témata: article
• On-line přístup: Connect to this object online.

Abstract Introduction Neuroblastoma (NB) is the most common extracranial solid tumor among children. The 5‐year event‐free survival rate for high‐risk (HR) NB is still poor, especially for patients with advanced NB with MYCN gene amplification. Chimeric antigen receptor T (CAR‐T) cell therapy is a n...